Tectonic Therapeutic (TECX) Non-cash Items (2017 - 2026)
Tectonic Therapeutic (TECX) reported Non-cash Items of $28.7 million for Q1 2026, up 18895.36% year-over-year from N/an in Q1 2025, and up 23.63% quarter-over-quarter from $23.2 million in Q3 2025.
Tectonic Therapeutic (TECX) Non-cash Items (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Non-cash Items data on file, last reported at $28.7 million in Q1 2026.
- Non-cash Items for Q1 2026 came in at $28.7 million, up 18895.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.7 million (up 18895.36% YoY), and the FY2024 annual result was $2.9 million, up 27.55% from the prior year.
- Non-cash Items rose to $28.7 million in Q1 2026 per TECX's latest filing, from $23.2 million in the prior quarter.
- Over five years, Non-cash Items peaked at $33.5 million in Q3 2024 and troughed at $22000.0 in Q4 2022.
- A 5-year average of $8.4 million and a median of $3.5 million in 2022 frame the typical range for Non-cash Items.
- The sharpest annual moves came in 2022 and 2026: Non-cash Items tumbled 98.5% in 2022, then jumped 18895.36% in 2026.
- A 5-year view of Non-cash Items shows it stood at $22000.0 in 2022, then soared by 10245.45% to $2.3 million in 2023, then advanced by 27.55% to $2.9 million in 2024, then surged by 699.17% to $23.2 million in 2025, then advanced by 23.63% to $28.7 million in 2026.
- Business Quant data shows TECX's Non-cash Items at $28.7 million in Q1 2026, $23.2 million in Q3 2025, and $151000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.68 Mn |
| Mar 31, 2026 | 28.68 Mn |
| Sep 30, 2025 | 23.20 Mn |
| Sep 30, 2025 | 23.20 Mn |
| Mar 31, 2025 | 151,000.00 |
| Mar 31, 2025 | 151,000.00 |
| Dec 31, 2024 | 2.90 Mn |
| Dec 31, 2024 | 2.90 Mn |
| Sep 30, 2024 | 33.50 Mn |
| Sep 30, 2024 | 33.50 Mn |
| Mar 31, 2024 | 3.64 Mn |
| Mar 31, 2024 | 3.64 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Sep 30, 2023 | 6.28 Mn |
| Sep 30, 2023 | 6.28 Mn |
| Jun 30, 2023 | 4.18 Mn |
| Jun 30, 2023 | 4.18 Mn |
| Mar 31, 2023 | 3.86 Mn |
| Mar 31, 2023 | 3.86 Mn |